Omnicell (OMCL) Debt Ratio (2016 - 2025)

Omnicell's (OMCL) quarterly Debt Ratio came in at 0.08 in Q2 2025, little changed quarter-over-quarter from 0.08 in Q1 2025.

Analysis

Omnicell (OMCL) Debt Ratio (2016 - 2025) Analysis & Trends

Omnicell (OMCL) has reported Debt Ratio for 8 consecutive years, with 0.08 the latest figure, recorded in Q2 2025.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.08 in Q2 2025; TTM through Jun 2025 was 0.08, a N/A change from a year earlier, with the FY2024 full-year figure at 0.08, changed N/A from the prior year.
Debt Ratio was 0.08 for Q2 2025 at Omnicell, roughly flat from 0.08 in the prior quarter.
Over five years, Debt Ratio peaked at 0.27 in Q1 2022 and troughed at 0.08 in Q1 2025.
A 4-year average of 0.16 and a median of 0.16 in 2024 frame the typical range for Debt Ratio.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	187.42 Bn	182.47 Bn	7.27 Bn	0.30
2	Intuitive Surgical	129.78 Bn	124.69 Bn	1.96 Bn	-
3	Medtronic	120.53 Bn	112.33 Bn	6.34 Bn	0.30
4	Stryker	116.28 Bn	112.80 Bn	4.50 Bn	0.31
5	Boston Scientific	69.29 Bn	68.99 Bn	3.85 Bn	0.28
6	Edwards Lifesciences	51.83 Bn	47.68 Bn	1.35 Bn	0.04
7	Alcon	34.36 Bn	32.91 Bn	1.68 Bn	0.13
8	Dexcom	33.17 Bn	31.23 Bn	830.00 Mn	-
9	Resmed	32.94 Bn	31.47 Bn	861.22 Mn	0.10
10	Omnicell	1.57 Bn	1.28 Bn	152.94 Mn	-

Historic Data

Download Data